Overview
Han Liu practices in Shenyang, China. Liu is rated as an Experienced expert by MediFind in the treatment of Hypophosphatasia (HPP). Their top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Hypophosphatasia (HPP).
Their clinical research consists of co-authoring 41 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Hypophosphatasia (HPP).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerLiu isExperienced. Learn about Breast Cancer.
- Hypophosphatasia (HPP)Liu isExperienced. Learn about Hypophosphatasia (HPP).
- Lung AdenocarcinomaLiu isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerLiu isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)